These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16354213)
1. Effects of montelukast on symptoms and eNO in children with mild to moderate asthma. Lee MY; Lai YS; Yang KD; Chen CJ; Hung CH Pediatr Int; 2005 Dec; 47(6):622-6. PubMed ID: 16354213 [TBL] [Abstract][Full Text] [Related]
2. Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment. Hung CH; Jong YJ; Hua YM; Li CY; Lai YS; Yang KD; Chang HC Pulm Pharmacol Ther; 2007; 20(3):233-9. PubMed ID: 17276712 [TBL] [Abstract][Full Text] [Related]
3. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829 [TBL] [Abstract][Full Text] [Related]
4. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Straub DA; Minocchieri S; Moeller A; Hamacher J; Wildhaber JH Chest; 2005 Feb; 127(2):509-14. PubMed ID: 15705989 [TBL] [Abstract][Full Text] [Related]
5. Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma. Chuang SS; Hung CH; Hua YM; Tien CH; Yang KD; Jong YJ; Hsu SH; Lin CS Pediatr Int; 2007 Dec; 49(6):918-22. PubMed ID: 18045297 [TBL] [Abstract][Full Text] [Related]
6. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563 [TBL] [Abstract][Full Text] [Related]
7. Effects of exercise training and montelukast in children with mild asthma. Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200 [TBL] [Abstract][Full Text] [Related]
8. Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Bratton DL; Lanz MJ; Miyazawa N; White CW; Silkoff PE Pediatr Pulmonol; 1999 Dec; 28(6):402-7. PubMed ID: 10587413 [TBL] [Abstract][Full Text] [Related]
9. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Bisgaard H; Loland L; Oj JA Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811 [TBL] [Abstract][Full Text] [Related]
10. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Fritscher LG; Rodrigues MT; Zamel N; Chapman KR Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684 [TBL] [Abstract][Full Text] [Related]
11. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children. Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698 [TBL] [Abstract][Full Text] [Related]
12. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930 [TBL] [Abstract][Full Text] [Related]
13. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma. Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233 [TBL] [Abstract][Full Text] [Related]
14. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723 [TBL] [Abstract][Full Text] [Related]
15. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma. Athavale A; Souza GA; Avasthi R; Singh NP; Kale M; Taneja A; Sireesha K J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214 [TBL] [Abstract][Full Text] [Related]
16. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757 [TBL] [Abstract][Full Text] [Related]
17. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221 [TBL] [Abstract][Full Text] [Related]
18. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Robinson DS; Campbell D; Barnes PJ Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132 [TBL] [Abstract][Full Text] [Related]
20. [Effect of montelukast sodium on TGF-beta(1) of peripheral blood mononuclear cells from children with mild persistent asthma]. Hong JG; Dong WF; Zhou XJ Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):679-84. PubMed ID: 22176903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]